Plasticell

Plasticell is a biotechnology company specializing in the development of novel therapies by precisely manipulating stem cells and differentiated cell types. Utilizing award-winning combinatorial screening technology, Plasticell optimizes protocols for cell expansion, differentiation, gene transduction, and biomolecule production. The company serves clients in the pharmaceutical and healthcare sectors, focusing on cancer and rare disease indications. Operating in the biotechnology market, Plasticell generates revenue through partnerships, licensing agreements, and the provision of human cells for drug discovery. The business model is centered on leveraging its proprietary technology to create advanced cell and gene therapies, as well as drugs discovered through screening rare human cell types derived from stem cells.

Keywords: biotechnology, stem cells, gene therapy, cell expansion, drug discovery, cancer, rare diseases, combinatorial screening, healthcare, pharmaceutical.